Elena Ioana Braicu

Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment

Karen Hoffmann, Hilmar Berger, Hagen Kulbe et al. · The EMBO Journal · 2020 · 248 citations · Full text

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma

Silvia Darb‐Esfahani, Catarina Alisa Kunze, Hagen Kulbe et al. · Oncotarget · 2015 · 236 citations · Full text

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

Oncology, Cervical Cancer, Metronomic Therapy +6

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

Otávio Cabral-Marques, Alexandre H. C. Marques, Lasse M. Giil et al. · Nature Communications · 2018 · 165 citations · Full text

An Illegitimate microRNA Target Site within the 3′ UTR of <i>MDM4</i> Affects Ovarian Cancer Progression and Chemosensitivity

Jessika Wynendaele, Anja Böhnke, Eleonora Leucci et al. · Cancer Research · 2010 · 164 citations · Full text